RxDoctor Payments DataLook up a doctor →

Mitchell Weinberg, MD

Interventional Cardiology · Manhasset, NYNPI 1245498385

Payments from drug & device makers

$779,300in general payments, 2019–2025

Across 604 payments — averaging $1290.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inari Medical, Inc.$266K
  • Boston Scientific$261K
  • Abbott$86K
  • Medtronic$86K
  • Microvention, Inc.$61K
  • Neptune Medical Inc.$5K
  • plus $14K from 20 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$779,300 in reported general payments places this provider in the 90th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York

Medicare billing

Part B allowed, 2024
$126,443
Medicare patients
218
Services billed
772

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Manhasset

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →